The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study

Key Points

• This research aims to quantify the economic burden of chronic obstructive pulmonary disease (COPD) across 204 countries and territories from 2020 to 2050.
• Health-augmented macroeconomic modelling implemented to assess financial impacts.
• Analysis conducted on a global scale, covering 204 regions.
• Cost implications assessed for different time frames up to 2050.
• Projected significant economic losses attributed to COPD, straining healthcare resources and national economies.
• Increased prevalence of COPD expected to escalate direct and indirect costs over the specified period.
• Findings highlight the need for improved preventive measures and healthcare policies to mitigate economic impacts.